| Friday, November 20th 2020 Recording of TreatER webcast seminar – World’s first clinical trial with CDNF: Aiming for a breakthrough in Parkinson’s Read More | Tuesday, September 15th 2020 Recording of webinar – CDNF Phase I-II Study Met Primary Endpoints of Safety and Tolerability at 12 months Read More | Friday, September 11th 2020 Registration open for TreatER webcast seminar on 18 November 2020 – World’s first clinical trial with CDNF: Aiming for a breakthrough in Parkinson’s Read More | Thursday, August 27th 2020 Renishaw announces completion of clinical trial extension study, using its innovative drug delivery system in the investigation of CDNF as a treatment for Parkinson’s disease Read More | Thursday, August 27th 2020 Herantis Pharma Plc Announces CDNF Phase I-II Study Met Primary Endpoints of Safety and Tolerability at 12 months Read More